Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

Carolyn M. Klotzbuecher, Philip D. Ross, Pamela B. Landsman et al. · Journal of Bone and Mineral Research · 2000 · 2K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +17

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment

Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

Medicine, Endocrinology, Bone Metabolism +12